We are proud to name Zsofia Stadler, MD from
@mskcancercenter.bsky.social the next Editor-in-Chief of JCO Precision Oncology starting July 1st. Dr. Stadler’s expertise will drive the integration of genomics & AI into cancer research for improved patient outcomes. Read more: bit.ly/4aoLPyZ
#JCOPO
We're thrilled to be here on BlueSky to bring you the latest practice-changing oncology research from all six JCO Journals! Follow-us for great content from #JCO, #JCOOP, #JCOGO, #JCOPO, #JCOCCI, & #JCOOA.
Generalized Evolutionary Classifier for Evolutionary Guided Precision Medicine ascopubs.org/doi/10.1200/... #JCOPO #OpenAccess
Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation ascopubs.org/doi/10.1200/... #JCOPO #PrecisionOnc #JCOJournals #OpenAccess
Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 Trial ascopubs.org/doi/10.1200/...
#JCOPO #JCOJournals #PrecisionOncology #OpenAccess
Out now in #JCOPO: Optimizing Radiotherapy Timing for Nasopharyngeal Carcinoma: The Impact of Radiation Scheduling on Survival #https://ascopubs.org/doi/10.1200/PO-24-00603
#precisiononcology, #JCOJournals, #openaccess
Parents' Experiences With and Preferences for Receiving Information About Tumor Genomic Sequencing: Findings From a Qualitative Study and Implications for Practice #JCOPO #precisiononcology #oncsky #caregivers #JCOJournals ascopubs.org/doi/10.1200/...